(07-21-2021, 11:10 AM)hegel Wrote: I'm suggesting that random people voicing opinions on the internet who brook no disagreement with their opinions are not the best sources for information on this important issue. Or other issues. I'm calling for reasonable, fact based discussion.

(07-21-2021, 12:46 PM)WakeUpTime Wrote: Those of us who are continuing to use our recalled defective Philips systems each night, contrary to the manufacturer's demand not to, certainly don't want to think that we could be inhaling cancer-causing foam particles each night during our PAP therapy.  

At this stage, more (independent) laboratory analysis should immediately be performed on real-life (not laboratory simulated) recalled Philips systems and their defective sound-absorbing foam.  After using this defective foam for more than 10 years, it's clear that the company (and perhaps the industry) is unable to police themselves in consumer health protection.

(07-21-2021, 01:08 PM)hegel Wrote: I believe that both English and Canadian health agencies are recommending people continue using machines until a replacement is available. That suggests that they don't find a high degree of danger exists for most users.

(07-21-2021, 01:47 PM)hegel Wrote:
The included link is https://cts-sct.ca/wp-content/uploads/20...9_2021.pdf
It's 8 pages, too long to copy in full. In brief, after discussion with their doctor, most patients should continue using the machine until it can be replaced with an unaffected machine, preferably sooner than later.

Quote:(1) For patients using affected devices that are considered life-sustaining (see above for description) physicians should discuss risks and benefits with their patients as soon as possible to determine the best course of action.  For life-sustaining devices, this would very likely involve obtaining a comparable non-recalled device or, if this is not possible, to continue the recalled device until repair/replacement.  Other experts involved in the care of these patients (such as respiratory therapists) could be helpful in these discussions, but the ultimate decision about continuing or stopping therapy remains with the physician and patient. If the device is changed to a non-recalled device or any modifications are made to the circuit (e.g., addition of a filter - see below), close follow-up and optimization of therapy (e.g., potentially changing pressures, triggering sensitivities) are necessary to ensure continued adequate ventilatory support and patient comfort. 

(2) For patients using affected CPAP or Bi-Level devices at night for obstructive sleep apnea, therapeutic decisions should be individualized. Discussion between patient and physician might also provide an opportunity to reconsider indications and effectiveness of therapy. 

(07-21-2021, 01:39 PM)WakeUpTime Wrote: Could you please indicate where those governments have specifically stated that recalled device users should continue using their machines until a replacement is available?  

Perhaps they're referring to those that are using a ventilator in an invasive life-sustaining manor.  Otherwise, I don't think a government health agency would come out and contradict the advice of a defective product manufacturer.

Anyone that advices to continue using the recalled Philips systems is absolutely not stating that they've certified it to not represent any degree of danger.  They may simply be stating that it may be significantly more dangerous to stop without seeking medical advice, thus protecting those agencies from liability.

•         Stopping use of your device
  
  
  
  • Continuing to use your affected device, if your health care provider determines that the benefits outweigh the risks identified in the recall notification.
    

• Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication | FDA

(07-21-2021, 03:02 PM)btreger Wrote: This is from the FDA:

• • Continuing to use your affected device, if your health care provider determines that the benefits outweigh the risks identified in the recall notification.